https://www.selleckchem.com/pr....oducts/Odanacatib-(M
75 [95% CI 0.64-0.88; p=0.0004; I 2=97%]. The RR for CVD, cancer related and CVA deaths were 0.74 [95% CI 0.62-0.88; p=0.0006, I 2=66%], 0.77 [95% CI 0.71-0.84; p=0.0001; I 2=49%] and 0.76 [95% CI 0.36-1.60; p=0.47; I2=93%], respectively. Statistically significant results of our analysis put forward a rationale indicating an association between lower risk of all-cause, cardiovascular and cancer related deaths and CP consumption. Statistically significant results of our analysis put forward a rationale indicating an associati
Like
Comment
Share
